Drug intelligence / Profile preview

Kamol

Development stage: Unknown
Modality: Hydrogel Systems → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

Kamol is a topical analgesic medicinal product formulated with essential oils, including eucalyptus oil and related counter-irritant components, used as a local adjunctive treatment for muscle and tendinoligamentous pain. By providing a counter-irritant effect and enhancing local blood flow at the application site, it helps reduce the perception of musculoskeletal pain when applied to intact skin over affected areas. It is marketed as an over-the-counter remedy in certain countries and is intended for short-term, symptomatic relief rather than disease modification.

Brand names: Kamol

Beyond the preview

Go deeper on Kamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kamol.

Explore the full profile